Clinical features, risk factors, and outcome of cerebral venous thrombosis in Tehran, Iran.
BACKGROUND
Despite increasing the use of magnetic resonance imaging (MRI), cerebral venous sinus thrombosis (CVST) has remained an under-diagnosed condition. In this study, characteristics and frequency of various risk factors of CVST patients in a tertiary referral hospital were closely assessed.


METHODS
Patients with an unequivocal diagnosis of CVST confirmed by MRI and magnetic resonance venography during 6 years of the study were included. All data from the onset of symptoms regarding clinical signs and symptoms, hospital admission, seasonal distribution, medical and drug history, thrombophilic profile, D-dimer, neuroimaging, cerebrospinal fluid findings, mortality, and outcome were collected and closely analyzed.


RESULTS
A total of 53 patients with female to male ratio of 3.07 and mean age of 33.7 years were included in the study. Headache and papilledema were the most frequent clinical features (44 and 36 patients, respectively). An underlying disease (diagnosed previously or after admission) was the most common identified risk factor for CVST in both females and males (21 patients). A total of 15 women used the oral contraceptive pill (OCP) where 12 of them had simultaneously other predisposing factors. Overall, 19 patients (36%) had more than one contributing factor. D-dimer had a sensitivity of 71.4% in CVST patients. The mortality of patients in this study was 3.7% (n= 2). Focal neurologic deficit and multicranial nerve palsy were associated with poor outcome which defined as death, recurrence, and massive intracranial hemorrhage due to anticoagulation (P= 0.050 and 0.004, respectively).


CONCLUSIONS
Unlike most of the CVST studies in which OCP was the main factor; in this study, an underlying disease was the most identified cause. Considering the high probability of multiple risk factors in CVST that was shown by this study, appropriate work up should be noted to uncover them.
Department of Neuro-ophthalmology, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran; Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Samira
S
Yadegari
Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Askar
A
Ghorbani
Department of Surgery, Institute of Cancer, Tehran University of Medical Sciences, Tehran, Iran.
S Roohollah
SR
Miri
Research Center of Medical Students, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad
M
Abdollahi
Research Center of Medical Students, Tehran University of Medical Sciences, Tehran, Iran.
Mohsen
M
Rostami
Cerebral venous sinus thrombosis; etiology; oral contraceptive pill; outcome; risk factor
J Neurol Sci. 2013 Apr 15;327(1-2):12-4
23434247
Can J Neurol Sci. 2004 Nov;31(4):474-7
15595250
Thromb Haemost. 2009 Oct;102(4):620-2
19806246
Iran Red Crescent Med J. 2012 Dec;14(12):805-10
23483618
Acta Neurol Scand. 2008 Feb;117(2):117-21
18184347
Stroke. 2004 Mar;35(3):664-70
14976332
Clin Appl Thromb Hemost. 2004 Jul;10(3):277-80
15247986
J Pak Med Assoc. 2006 Nov;56(11):513-6
17183979
Thromb Res. 2007;121(3):301-7
17543373
Hematology. 2013 Mar;18(2):119-22
23321260
J Stroke Cerebrovasc Dis. 2012 Jul;21(5):395-400
21367622
Curr Neurol Neurosci Rep. 2014 Jan;14(1):417
24264471
J Thromb Haemost. 2012 Apr;10(4):582-9
22257124
Iran J Med Sci. 2011 Sep;36(3):178-82
23359749
Stroke. 2009 Jul;40(7):2356-61
19478226
Acta Neurol Taiwan. 2008 Jun;17(2):82-7
18686646
Neurosciences (Riyadh). 2011 Apr;16(2):129-36
21427662
Ital J Neurol Sci. 1999 Aug;20(4):231-5
10551909
N Engl J Med. 2005 Apr 28;352(17 ):1791-8
15858188
Acta Neurol Belg. 2010 Sep;110(3):230-3
21114130